Abstract. The major contributors to the pathogenesis of type 2 diabetes are impaired insulin action and insulin secretion, including second phase insulin secretion (2 nd ISEC). This study aimed to compare surrogates derived from the mixed meal tolerance test (MTT) with 2 nd ISEC derived from modified low-dose graded glucose infusion (M-LDGGI) in patients with type 2 diabetes. We were subsequently able to decide which surrogate would be performed easily and accurately. Twenty type 2 diabetes patients were enrolled. They received both MTT and M-LDGGI. The standardized MTT meals were provided at 8:00 A.M. and 12:00 P.M. The M-LDGGI was a simplified version of the Polonsky method; only two 80-min stages of glucose infusion (2 and 6 mg/kg/min) were given. The slopes of the insulin to glucose curve during the test were regarded as the 2 nd ISEC. First, we used the area under the insulin curve (AUC IN ) during MTT to quantify the 2 nd ISEC. The best correlated AUC IN was from 60-240 min. Second, the slopes between any two time points of the plasma insulin to glucose level (SLOPE I/G ) were also assessed. The time period best correlated with 2 nd ISEC was from 0-120 min (SLOPE 0-120 ). Finally, the insulin-toglucose ratio (IG r ) of each time point was used to estimate the 2 nd ISEC, and the best correlation was observed at 180 min. In conclusion, estimating 2 nd ISEC surrogates derived from MTT proved to be possible. The most accurate surrogate is the SLOPE 0-120 , while IG r180 is another less precise but more convenient method.
more accurately in type 2 diabetes patients in daily practice.
Subjects and Methods

Subjects
We enrolled 20 subjects with type 2 diabetes (10M/10F), aged between 40-65 years, who had received only oral hypoglycemic agents (OHA) from our outpatient clinic in Cardinal Tien Hospital. All these subjects were diagnosed as type 2 diabetes by 75g OGTT before they received OHA. The mean duration of diabetes was about 8.0 ± 3.4 years (0.5 years to 9.5 years) (Table 1) . Other than diabetes, the subjects had no significant medical diseases or history of diabetic ketoacidosis, nor had they taken any medications known to affect insulin sensitivity and/or β-cell function during the study period. After explaining the research details, written informed consent was obtained from each individual. The study was reviewed and approved by the Institutional Review Board (CTH-101-2-5-027).
Each participant undertook both the MTT and M-LDGGI randomly with an interval of at least three days between the two tests. The tests were performed at 8:00 A.M. with subjects in the sitting position after a 10-hour overnight fast. An intravenous catheter was placed in each forearm, one for blood sampling and one for glucose infusion (only during M-LDGGI). The sampling catheters were kept patent by slow infusion few studies have focused on the role of insulin secretion compared to insulin resistance. Some studies have shown that first phase insulin secretion (1 st ISEC) nearly disappears even before type 2 diabetes is diagnosed [5] [6] [7] [8] , although second phase insulin secretion (2 nd ISEC) remains partially functional after the diagnosis [9] . This is important for glucose homeostasis when patients are still being treated with oral hypoglycemic agents. The role of 2 nd ISEC while important has been underestimated and less discussed in the literature.
There are several methods of measuring ISEC, such as homeostasis model assessment-β cell (HOMA-β) [10] , the oral glucose tolerance test (OGTT) [11] , and the frequent sampling intravenous glucose tolerance test (FSIGT) [12] . However, most of these tests measure 1 st ISEC only. At the same time, although lowdose graded glucose infusion (LDGGI) is considered to be more accurate and is focused on 2 nd ISEC [13] , it takes 4 hours and requires a mathematical method known as 'deconvolution' for calculation. This method requires special computer programs and thus cannot be done even in many research facilities. These two conditions limit the wide application of LDGGI. Our group proposed a modified LDGGI (M-LDGGI) and described its use in our previous study [14] . In brief, compared with the LDGGI, the M-LDGGI is shorter and contains fewer time points for blood drawing. At the same time, no deconvolution is needed.
Recently, due to the development of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase IV (DPP-4) inhibitors, the concept of insulin being stimulated by nutrients, other than plasma glucose only, entering the gastrointestinal tract has been more greatly appreciated [15] [16] [17] [18] . Thus, a mixed meal tolerance test (MTT) that contains all nutrients might be a better challenge. Indeed, some studies have investigated the use of MTT for estimating ISEC. However, most of these previously published MTT methods still require deconvolution in the calculation [19] . Again, this prohibits the widespread use of MTT.
The purpose of the present study was to find a relatively simple and yet accurate method for quantifying 2 nd ISEC. To accomplish this goal, both MTT and M-LDGGI were used with 20 subjects with type 2 diabetes. M-LDGGI was taken as the standard for quantifying 2 nd ISEC. Different surrogates derived from MTT were calculated and compared with M-LDGGI by simple correlation. Thus, we could ascertain which MTT surrogate could be used to estimate 2 nd ISEC Products Corp., Los Angeles, CA, USA). The cross-reactivity of the insulin assay with proinsulin at midcurve was about 40%. Intra-and inter-assay coefficients of variance for insulin were 3.3 and 2.5%, respectively. Plasma glucose was measured using a glucose oxidase method (YSI 203 Glucose Analyzer, Scientific Division, Yellow Springs Instrument Co. Inc., Yellow Springs, OH, USA). Serum total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were measured using the dry, multilayer analytical slide method in the Fuji DR-Chem 3000 analyzer (Fuji Photo Film Corp., Minato-ku, Tokyo, Japan). The level of HbA1C was evaluated by the ion-exchange high pressure liquid chromatography (HPLC) method (Bio-Rad Variant II, Hercules, CA, USA).
Surrogates for 2
nd ISEC We used 3 different methods to calculate 2 nd ISEC from the MTT. 1. Area under curve of plasma insulin levels between 2 time points (AUC IN , Table 2 ). AUC was calculated using the trapezoidal rule. 2. Slope of the plasma insulin-to-glucose ratio between 2 time points (SLOPE I/G ): This method further takes the effect of time of insulin secretion into account and is supposed to be more accurate (Table 3) . 3. The insulin/glucose ratio (IG r ): Since insulin secreof 0.9% saline.
After the catheters were inserted, the fasting samples were taken. All the other blood samplings were taken hourly until 4:00 P.M. to determine the plasma glucose and insulin concentration. The standardized MTT meals were isocaloric (30 kcal/kg), and each meal contained (as a percentage of the total energy) 15% protein, 33% fat, and 52% carbohydrates. The meals were provided at 8:00 A.M. and 12:00 P.M. and had 20% and 40% of the daily total caloric intake, respectively. M-LDGGI: The M-LDGGI is a simplified version of the original stepped intravenous infusion. Compared to the six stages proposed by Byrne et al. [13] , we administered two stages of glucose infusion (20% dextrose) only at the rate of 2 mg/kg/min, followed by 6 mg/kg/min. Each infusion was maintained for 80 min and blood samples were obtained at 20-min intervals for the measurement of plasma insulin and glucose levels. A regression line was drawn based on the plasma insulin levels (y-axis) against the plasma glucose levels (x-axis, Fig. 1 ) at each time point. The slope of this line was considered to be the standard for the 2 nd ISEC in this study.
The blood samples were centrifuged immediately and stored at -30C° until time of analysis. Plasma insulin was measured with a commercial solid phase radioimmunoassay kit (Coat-A-Count Insulin Kit, Diagnostic ISEC, HOMA-β, AUC IN, SLOPE I/G , and IG r showed a right-skew distribution, log transformation was done before further analysis. Correlations were evaluated by Pearson's correlation. The Bland-Altman plot was used to evaluate the agreement between the new method and the gold standard. Using r-to z transformation, z statistics were calculated and were used to determine the difference between any two r values. All statistical tests were two-sided and p ≤ 0.05 was considered to be significant.
tion is related to the plasma glucose level, this method could take the plasma glucose level into consideration (Table 4) . To compare our new indices from MTT with other available indices, the homeostatic model assessment of β-cell function (HOMA-β) was also calculated [10] .
Statistical analysis
Statistical analysis was performed with SPSS Version 10.0 for Windows (SPSS, Chicago, IL). Data the hyperglycemia clamp [20] . One important finding that is worth noting is that the range of the r values of AUC IN was relatively narrow (0.527 to 0.621). This implies that AUC IN might be a more reliable method than other surrogates discussed in this study.
The second surrogate we used was the SLOPE I/G between any two points during MTT. To our knowledge, this is a totally novel method to quantify the 2 nd ISEC. The beauty of this method is that the effect of time and glucose effects on insulin secretion are taken into consideration. However, the method requires two time points to obtain the slope, which makes it less convenient. From our data, the best correlated time period was SLOPE 0-120 . Our data are not surprising, since Tura et al. showed that that IGI in the first 30 min of the oral glucose tolerance test (IGI: ∆ Insulin0-30/∆ Glucose0-30) was highly related to the 1 st ISEC [21] . In that study, FSIGT to quantify the 1 st ISEC was used. The researchers further postulated that a similar ratio of glucose and insulin at 90-min time points might be related to 'late secretion'. Although the best correlated time period for our first surrogate was from 0-120 min (r = 0.807), it still covered the 90-min time point and thus was compatible with their suggestion. It should be noted that the correlations between SLOPE and 2 nd ISEC after 90 min still existed in the current study. This could be partially explained by the fact that during MTT, slow digestion due to multiple nutrients might play a role in this extension of the significant time period.
The last surrogate we used to estimate the 2 nd ISEC was the IG r . Among all the time points, the IG r at 180 min had the highest r value (0.613) ( Table 4 ). This finding is compatible with our two previous methods, since the 2 nd ISEC was expected sometime after 60 min. Despite these significant results, we still consider the IG r to be less accurate than the SLOPE I/G , because of its lower r value. However, this method does have some important implications. First, in the aforementioned study, Tura et al. [21] used a clamp to quantify the 2 nd ISEC, which is a well-recognized method. By being consistent with their results, our data are further validated. Second, although less accurate, this method only needs one time point to do the estimation. This makes the IG r more widely applicable in regular health facilities.
It would be of interest to compare our new indices with the traditional surrogates, the HOMA-β. Our three indices derived from MTT showed better correlation with the 2 nd ISEC than the traditional index. The
Results
The demographic data and indices of β-cell function of the study subjects, including the 2 nd ISEC derived from M-LDGGI, and HOMA-β are found in Table 1.  The standard 2 nd ISEC used in this study, which is the slope of the regression line, is also presented (Fig. 1) .
The first surrogate we used to estimate 2 nd ISEC was AUC IN . All the AUC IN were significantly correlated with the 2 nd ISEC ( Table 2 ). Among them, the AUC of 60-240 min was found to have the best correlation (AUC 60-240 ) (r = 0.621, p = 0.005).
With regard to the SLOPE I/G between any time point and its relationship with the 2 nd ISEC, the slope with the highest r value was between 0-120 min (SLOPE 0-120 , r = 0.807, p = 0.000) ( Table 3) . Finally, the relationships between IG r and 2 nd ISEC were calculated ( Table 4 ). 
Discussion
The aim of this study was to evaluate which surrogates are best correlated during MTT with the 2 nd ISEC in patients with type 2 diabetes. There were 3 different analyses of MTT, as we have shown in the Materials and Methods section. The first method we used was AUC IN . The drawback of this method is the necessity of two time points to do the calculation. Of all the time periods, the best correlated AUC IN was from 60-240 min (r = 0.621). This finding is not completely novel since a similar study was also done with children with normal glucose tolerance tests. Bacha et al. showed that, compared to either the 30 min or 60 min insulinogenic index (IGI), AUC IN during both OGTT and MTT were better correlated with the 2 nd ISEC calculated by they received OHA, only fasting plasma glucose and post-challenge 120 min glucose levels were measured. Many interesting indices derived from OGTT such as insulinogenic index 120 min, Stumvoll index and sigma insulin 0-120/sigma glucose 0-120, which required insulin levels, were unable to be calculated. It would be our future plan to do the comparison of the differences between indices from MTT and those from OGTT in type 2 diabetes.
In conclusion, we have demonstrated that it is possible to estimate 2 nd ISEC surrogates derived from MTT easily in daily practice. The most accurate surrogate is the SLOPE 0-120 . At the same time, IG r180 is another less precise but more convenient method that can be be used.
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concept behind HOMA-β is how much insulin can be driven per unit of glucose. It represents a static insulin secretion during the fasting status. On the other hand, both MTT and M-LDGGI are relatively more physiological, since they assess the dynamic response after glucose load. These results might contribute to the fact that HOMA-β did not show a better association with the 2 nd ISEC than indices derived from MTT. There are some limitations in our study. First, we chose a less well-documented method, the M-LDGGI, as the "gold standard" in our study. In theory, either the hyperglycemia clamp or LDGGI might be a better method. However, the M-LDGGI is less time-and effort-consuming. This method has been described by our group elsewhere [14] . Second, it is generally agreed that measuring C-peptide during MTT might be more accurate than insulin. However, we did not have the data for C-peptide. It would be interesting to compare the calculated insulin secretion between C-peptide and insulin. This would be an important issue in future studies. Third, we did not repeat MTT in the same individual twice, so the reproducibility of the new indices cannot be demonstrated in our study. Finally, although all subjects received OGTT before
